Tech Company Financing Transactions
TyRx Pharma Funding Round
TyRx Pharma, based in Monmouth Junction, received $25 million in funding from Clarus and Pappas Ventures.
Transaction Overview
Company Name
Announced On
2/28/2008
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Clarus (Lead Investor) (Scott Requadt)
Pappas Ventures (Lead Investor) (Arthur Pappas)
Proceeds Purpose
Company CEO William Edelman said, "The funds from the current financing round will enable our continuing transition from the development stage to commercialization, targeting the market in medical device infection control estimated at $3 billion in the United States."
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1 Deer Park Drive G
Monmouth Junction, NJ 08852
USA
Monmouth Junction, NJ 08852
USA
Phone
Website
Email Address
Overview
TyRx is dedicated to designing, developing, and commercializing next-generation resorbable polymeric biomaterials. The Company's first series of tyrosine-based resorbable polymer systems have been created for use in drug delivery and medical device applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert White
Chief Financial Officer
Ray Imp
Chief Medical Officer
Daniel Lerner
VP - Marketing
Randy Mansfield
VP - Product Management
William McJames
VP - Regulatory Affairs
Mark Citron
VP - Regulatory Affairs
Susan Olinger
VP - Sales
Fernando Ochoa
Browse more venture capital transactions:
Prev: 2/28/2008: Helpstream venture capital transaction
Next: 2/28/2008: Waywire Enterprise venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs